Chronic Disease Management Brief2026-11-02Four life stages for women's heart risk, one agreed definition for failing livers, and what a potassium pill does to blood pressureFive documents published October 26 to November 1 translate a four-stage framework for women's heart risk, one global definition of acute-on-chronic liver failure, a Lancet test of 30 liver tests, a potassium-and-blood-pressure review, and a GLP-1 comparison in people on dialysis into questions for your next appointment.2
Chronic Disease Management Brief2026-10-26A first drug guideline for PBC, who keeps diabetes in remission, and what a calcium score at 40 predictsFive documents published October 19-25, 2026 translate a first medication guideline for primary biliary cholangitis, two decades of data on what now causes drug-induced liver injury, who keeps type 2 diabetes in remission, a 30-year look at calcium scores in adults under 45, and a large safety comparison of two diabetes drug classes into questions for your next appointment.1
Chronic Disease Management Brief2026-10-19A glucose monitor without insulin, exercise on a prescription pad, and a heart risk that hides in the liverFive updates published October 12-18, 2026 translate a glucose-monitor trial in type 2 diabetes without insulin, an ACC statement on prescribing exercise, an AHA statement on two blood thinners after a stent, a review tying liver disease to heart risk, and a PCOS fatty-liver drug trial into questions you can bring to your next appointment.2
Chronic Disease Management Brief2026-10-12Vaccines and scans for cirrhosis, blood pressure that resists three drugs, and diabetes results nobody acted onFive updates published October 5-10, 2026 translate a first-ever cirrhosis prevention guideline, a new pathway for stubborn blood pressure, a national gap in diabetes diagnosis, an automated insulin pump trial, and a change in who the blood pressure guideline treats into questions you can bring to your next appointment.
Chronic Disease Management Brief2026-10-05Starting diabetes medicines earlier, blood thinners people go without, and a shorter hepatitis C cureFive updates published between September 28 and October 2 translate a new type 2 diabetes consensus, a blood-thinner care gap, the ACC's diet guidance, an oral GLP-1 trial, and a shorter hepatitis C cure into practical questions for your next appointment.1
Chronic Disease Management Brief2026-09-28Diabetes devices in the hospital, two kidney medicines together, and a blood test for liver cancerFive updates published between September 22 and 27 turn hospital care for diabetes devices, a two-drug kidney approach, semaglutide's heart benefit, cardiac rehabilitation timing, and liver cancer screening into practical questions for your next appointment.1
Chronic Disease Management Brief2026-09-21Diabetes distress, women's kidney care, and a fall-prevention plan for cirrhosisFive clinical updates published between September 15 and 18 turn diabetes distress, women's kidney health, falls in cirrhosis, and drinking habits into practical questions for your next appointment.2
Chronic Disease Management Brief2026-09-14Heart valve infections, type 1 diabetes kidney health, and noninvasive liver testsThree clinical updates published between September 8 and 14 translate heart valve infections, type 1 diabetes kidney therapies, and noninvasive liver tests into practical appointment questions.1
Chronic Disease Management Brief2026-09-07Medication routines, emergency heart symptoms, and a more tailored MASH planFour new September findings turn medication routines, emergency heart symptoms, and MASH treatment into clearer questions for your next appointment.2
Chronic Disease Management Brief2026-08-31A new heart-attack vocabulary, home blood pressure, and fear of lowsFour updates published this week help patients and caregivers ask clearer questions about heart-attack categories, home blood pressure, fear of low blood sugar, and MASLD follow-up.2
Chronic Disease Management Brief2026-08-24Atrial fibrillation, statins, and liver risk: 3 questions for your next visitThis week’s brief explains a new atrial-fibrillation care checklist, the cardiovascular risk that can remain while taking a statin, and what a new tirzepatide-versus-semaglutide liver study means for your next appointment.
Chronic Disease Management Brief2026-08-17Postpartum risk, functional fitness, and liver fat: 3 findings to discuss this weekThree new studies widen the next appointment checklist: postpartum cardiometabolic follow-up after gestational diabetes, safe functional-fitness measures for older adults, and what a small two-week liver-fat diet study can and cannot tell patients with MASLD.1